Dr. Yin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7154 Medical Center Dr
Spring Hill, FL 34608Phone+1 352-596-1926Fax+1 352-597-2154
Summary
- Dr. Faye Yin is an Oncologist based in Jersey City, NJ with experience in treating amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. She completed her Internal Medicine residency at Good Samaritan Hospital of Maryland and her Hematology and Medical Oncology fellowship at the National Institutes of Health Clinical Center. From 2013 to 2020, she worked as a Hematologist/Oncologist at UPMC Western Maryland. Dr. Yin has several publications under her name, published in esteemed journals like Bone Marrow Transplant, Leukemia & Lymphoma, Journal of Thoracic Oncology, and Stem Cells.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 2007 - 2010
Southern Medical UniversityClass of 1992
Certifications & Licensure
FL State Medical License 2021 - 2026
NJ State Medical License 2020 - 2025
MD State Medical License 2009 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsAcquired thrombotic thrombocytopenic purpura following Pfizer COVID-19 vaccinationMawaddah Alislambouli, Andy Veras Victoria, Jyoti Matta, Faye Yin
Ejhaem. 2021-11-16 - 1 citationsNovel BRCA2 c.8434_8435insTT (p. Gly2812Valfs*10) mutation in a family with multiple hematologic malignancies and solid tumorsFaye Yin, Ben Kosewski, Maria R. Baer
Leukemia & Lymphoma. 2021-04-16 - 141 citationsDurvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II StudyAnish Thomas, Rasa Vilimas, Christopher Trindade, Rebecca A. Erwin-Cohen, Nitin Roper
Journal of Thoracic Oncology. 2019-08-01
Press Mentions
Mountainside Medical Center Recognized for Antimicrobial StewardshipMarch 16th, 2023- Steeplechase Cancer Center Somerset Expands Medical Oncology ServicesMarch 16th, 2023
- Sophisticated Cancer Diagnosis Technology Now Offered at Jersey City Medical CenterFebruary 19th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
